Massachusetts Society of Clinical Oncologists (MSCO) 30th Anniversary Annual Meeting and Award Presentation

After participating in this activity, attendees should be able to:
• Assess the current limitations of single agent targeted therapies
• Explain the molecular basis of clonal diversity and drug resistance
• Describe the potential and the limitations of current approaches to monitoring for drug resistance
•Discuss the rationale and challenges of combination therapies